Latest News and Press Releases
Want to stay updated on the latest news?
-
Avant! AI new release is planned in May 2023 SAN DIEGO, March 14, 2023 (GLOBE NEWSWIRE) -- GBT Technologies Inc. (OTC PINK: GTCH) ("GBT”, or the “Company”), through its partially owned subsidiary,...
-
Low risk for drug-drug interactions with bemnifosbuvir based upon results from in vitro metabolism and transporter studies Bemnifosbuvir retains activity against all SARS-CoV-2 variants of concern...
-
First cohort of Larimar’s Phase 2 dose exploration trial of CTI-1601 in participants with Friedreich’s ataxia (FA) is fully enrolled and proceeding as plannedLarimar expects to provide an update on...
-
Luton, Bedfordshire, United Kingdom, March 14, 2023 (GLOBE NEWSWIRE) -- Exactitude Consultancy, the market research and consulting wing of Ameliorate Digital Consultancy Private Limited has...
-
NEW YORK, March 13, 2023 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that it is investigating whether the directors and/or officers of Veru, Inc. (“Veru” or the “Company”) (NASDAQ:...
-
Hyderabad, March 13, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled, “UAE Luxury Goods Market-2023-2028", the UAE luxury goods market is expected to grow at a CAGR of...
-
Redding, California, March 13, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled, ‘Neuromodulation Systems Market by Type (Spinal Cord, Sacral Nerve, Vagus Nerve, Deep Brain...
-
FREDERICK, Md., March 13, 2023 (GLOBE NEWSWIRE) -- Little Leaves Behavioral Services, a leading provider of center-based behavioral health services for preschool-aged children on the autism...
-
-The TGFβ1 and TGFβ3 isoforms are predictive --Validation of TGFβ2 as therapeutic target AGOURA HILLS, Calif., March 13, 2023 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC)...
-
MIDAS (mass spectrometry integrated with equilibrium dialysis for the discovery of allostery systematically), in-licensed and industrialized by Atavistik Bio as the basis of AMPS, is the first...